ஓத்சுக் மருத்துவ சாதனங்கள் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஓத்சுக் மருத்துவ சாதனங்கள் இணை லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஓத்சுக் மருத்துவ சாதனங்கள் இணை லிமிடெட் Today - Breaking & Trending Today

ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypert

ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypert
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France General , United States , Michel Azizi , Andrewm Weiss , Ajayj Kirtane , Georges Pompidou , Hypertension Excellence Center , American College Of Cardiology , Tokyo Stock Exchange , Otsuka Medical Devices Co Ltd , Recor Medical Inc , Otsuka Holdings Co Ltd , Recor Medical , Ultrasound Renal Denervation System , American College , Paradise Ultrasound Renal Denervation System , Paradise System , Columbia University Vagelos College , Professor Michel Azizi , Excellence Center , Recor President , Cor Medical , Palo Alto , Medical Devices , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் ஷீஜி ,

ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypertension

(1)
PALO ALTO, Calif., May 16, 2021 /PRNewswire/ ReCor Medical, Inc. ( ReCor ), a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd., today presented the primary endpoint data from the randomized sham-controlled RADIANCE-HTN TRIO ( TRIO ) study. In subjects with resistant hypertension, those treated with the Paradise Ultrasound Renal Denervation System had a greater drop in blood pressure than those who received a sham procedure. TRIO results were presented today at the American College of Cardiology meeting (https://accscientificsession.acc.org/) and published simultaneously in The Lancet.
The TRIO study evaluated the efficacy and safety of the Paradise Ultrasound Renal Denervation System in hypertensive patients who were all treated with a single pill containing 3 standardized anti-hypertension medications (a calcium-channel blocker, an angiotensin II receptor blocker, and a thiazide diuretic). After confirmation of inadequately controlled hypertension despi ....

France General , United States , Kostenloser Wertpapierhandel , Michel Azizi , Andrewm Weiss , Ajayj Kirtane , Georges Pompidou , Prnewswire Recor Medical Inc , American College Of Cardiology , Hypertension Excellence Center , Otsuka Medical Devices Co Ltd , Tokyo Stock Exchange , Otsuka Holdings Co Ltd , Recor Medical Inc , Cor Medical , Paradise Ultrasound Renal Denervation System , American College , Paradise System , Columbia University Vagelos College , Professor Michel Azizi , Excellence Center , Recor President , Recor Medical , Palo Alto , Medical Devices , பிரான்ஸ் ஜநரல் ,

Japan Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires and Coronary Stents

Press release content from Business Wire. The AP news staff was not involved in its creation.
Japan Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires and Coronary Stents - ResearchAndMarkets.com
January 8, 2021 GMT
DUBLIN (BUSINESS WIRE) Jan 8, 2021
ADVERTISEMENT
This is a comprehensive databook report, covering key market data on the Japan Interventional Cardiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS) and PTCA Balloon Catheters.
The Japan Interventional Cardiology Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025. ....

United States , B Braun Melsungen , Laura Wood , Company Share , Company Overview , Office Hours Call , E St Office Hours Call , Asahi Intecc Co Ltd , Overview Of Key Companies , Medtronic Plc , Japan Lifeline Co Ltd , Boston Scientific Corp , Abbott Laboratories , Otsuka Medical Devices Co Ltd , Microport Scientific Corp , Terumo Medical Corp , Interventional Cardiology Market Outlook , Coronary Guidewires , Coronary Stents , Japan Interventional Cardiology , Intravascular Ultrasound Systems , Japan Interventional Cardiology Market , Interventional Cardiology , Ultrasound Systems , Topics Covered , Cardiology Market ,

ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise Ultrasound Renal Denervation System

(1)
PALO ALTO, Calif., Dec. 10, 2020 /PRNewswire/ ReCor Medical, Inc. ( ReCor ), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise Ultrasound Renal Denervation System (the Paradise System ) demonstrated positive results in the RADIANCE-HTN TRIO ( TRIO ) study, and, separately, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with uncontrolled hypertension who are inadequately responsive to anti-hypertensive medications.
The RADIANCE-HTN TRIO trial evaluated the efficacy and safety of the Paradise System - a catheter-based system designed to denervate the renal nerves with ultrasound energy - to reduce blood pressure in hypertensive patients (n=136) wherein all subjects were placed on a single-pill combination-drug containing 3 anti-hypertension medications (a calcium-channel blocker, an angiotensin II-receptor blocker, and a diuretic). After confirmation of i ....

United States , Leslie Coleman , Kostenloser Wertpapierhandel , Michel Azizi , Andrewm Weiss , Ajayj Kirtane , Prnewswire Recor Medical Inc , Drug Administration , Affairs At Recor , Breakthrough Devices Program , Columbia University Vagelos College Of Physicians , Otsuka Medical Devices Co Ltd , Tokyo Stock Exchange , Recor Medical Inc , Otsuka Holdings Co Ltd , Cor Medical , Otsuka Medical Devices , Paradise Ultrasound Renal Denervation System , Breakthrough Device Designation , Paradise System , Columbia University Vagelos College , Professor Michel Azizi , Breakthrough Device , Devices Program , Breakthrough Designation , Vice President ,

ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise™ Ultrasound Renal Denervation System

Share this article
Share this article
PALO ALTO, Calif., Dec. 10, 2020 /PRNewswire/ ReCor Medical, Inc. ( ReCor ), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise™ Ultrasound Renal Denervation System (the Paradise System ) demonstrated positive results in the RADIANCE-HTN TRIO ( TRIO ) study, and, separately, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with uncontrolled hypertension who are inadequately responsive to anti-hypertensive medications.
The RADIANCE-HTN TRIO trial evaluated the efficacy and safety of the Paradise System – a catheter-based system designed to denervate the renal nerves with ultrasound energy – to reduce blood pressure in hypertensive patients (n=136) wherein all subjects were placed on a single-pill combination-drug containing 3 anti-hypertension medications (a calcium-channel blocker, an angiotensin II-receptor bloc ....

United States , Leslie Coleman , Michel Azizi , Andrewm Weiss , Ajayj Kirtane , Drug Administration , Affairs At Recor , Breakthrough Devices Program , Columbia University Vagelos College Of Physicians , Otsuka Medical Devices Co Ltd , Tokyo Stock Exchange , Otsuka Holdings Co Ltd , Recor Medical Inc , Recor Medical , Otsuka Medical Devices , Ultrasound Renal Denervation System , Breakthrough Device Designation , Paradise System , Columbia University Vagelos College , Professor Michel Azizi , Breakthrough Device , Devices Program , Breakthrough Designation , Vice President , Medical Affairs , Cor Medical ,